Screener
Iovance Biotherapeutics, Inc. IOVA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Selling, general, and administrative ** | 39,272 | 37,567 | 78,221 | 81,366 |
| Depreciation and amortization | 9,500 | 9,350 | 18,039 | 17,415 |
| Total costs and expenses | $151,218 | $173,726 | $303,691 | $344,271 |
| Loss from operations | (51,905) | (113,774) | (132,948) | (234,995) |
| Other income | ||||
| Interest and other income, net | 3,217 | 4,104 | 4,550 | 7,324 |
| Net Loss before income taxes | $(48,688) | $(109,670) | $(128,398) | $(227,671) |
| Income tax benefit (expense) | 1,373 | (1,988) | 2,038 | (150) |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s operating income?
- Iovance Biotherapeutics, Inc. (IOVA) reported operating income of -$51.91M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s operating income changed year-over-year?
- Iovance Biotherapeutics, Inc.'s operating income increased by 54.4% year-over-year, from -$113.77M to -$51.91M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s operating income?
- Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s operating income has grown at a 4.2% compound annual growth rate (CAGR), from -$342.7M to -$403.36M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Iovance Biotherapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude